NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/02/2026
Back to search
Official data from USPTO
FILLUNAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
06/02/2026
Trademark type
Word
Nice classes
5
Filing date
05/13/2025
Registration date
06/02/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/02/2026
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
NANNEY, KATHERINE N
Law office
O50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
BIONT Co., Ltd.
Representatives
Brian P. Gregg McNees Wallace & Nurick
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antiseptic preparations; medical hyaluronic acid in ampoule form for pharmaceutical purposes; drug delivery agents in the form of lyophilized formulations that facilitate the delivery of pharmaceutical preparations for the treatment of facial wrinkles and volume enhancement; medical preparations for the treatment of skin wrinkles and facial volume loss using drug delivery systems; chemical preparations for pharmaceutical usefor skin wrinkles and facial volume loss using drug delivery systems; cells for medical purposes; reagents for medical use; pharmaceutical preparations for the treatment of skin wrinkles and facial volume loss using drug delivery systems; diagnostic preparations for medical purposes; medical anti-aging serum; viscous fillers for wrinkle filling or volume augmentation being medical skin grafts; nucleic acid for medical purposes; medical hyaluronic acid preparations for pharmaceutical purposes; pharmaceutical skin lotions; pharmaceutical preparations for skin wrinkles and facial volume loss using drug delivery systems; surgical transplants comprising living tissues; pharmaceutical preparations for the treatment and prevention of skin wrinkles and facial volume loss using drug delivery systems; natural biomaterials for tissue recovery for medical purposes; pharmaceutical preparations for the treatment of wrinkles; injectable medical preparations for wrinkle filling in the form of gels; injectable dermal fillers for the treatment of wrinkles in the form of gels; injectable dermal fillers; injectable pharmaceuticals for treatment of skin wrinkles and facial volume loss using drug delivery systems; injectable dermal fillers for the treatment of forehead linesglabellar linestemple linescheek volume losscheekbone volume lossnasolabial folds linesmarionette lineslip lines; pharmaceutical preparation for skin care; bandages for skin wounds; pharmaceutical preparation for scar treatment
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/02/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/14/2026
PUBO
PUBLISHED FOR OPPOSITION
04/14/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/08/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/18/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/18/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/18/2026
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/18/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/09/2026
GNFR
FINAL REFUSAL E-MAILED
02/09/2026
CNFR
FINAL REFUSAL WRITTEN
02/09/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/07/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/07/2026
RFNT
REFUSAL PROCESSED BY IB
12/05/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/20/2025
RFRR
REFUSAL PROCESSED BY MPU
11/20/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/02/2025
CNRT
NON-FINAL ACTION WRITTEN
10/01/2025
DOCK
ASSIGNED TO EXAMINER
09/25/2025
MAFR
APPLICATION FILING RECEIPT MAILED
08/05/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/05/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/31/2025
Continuous trademark protection
Get notified about every new filing that threatens FILLUNAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.